Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|14|4|394-403

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.14, Iss.4, 2016-07, pp. : 394-403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Japanese postmarketing surveillance of clopidogrel for patients with non-ST-segment-elevation acute coronary syndrome indicated for percutaneous coronary intervention (J-PLACE NSTE-ACS)

By Morino Yoshihiro   Ako Junya   Kobayashi Masayuki   Nakamura Masato  

Cardiovascular Intervention and Therapeutics, Vol. 29, Iss. 2, 2014-04 ,pp. : 123-133

Springer Publishing Company

Access to resources Recommend Favorite

Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS)

By Bigalke Boris   Stellos Konstantinos   Weig Hans-Jörg   Geisler Tobias   Seizer Peter   Kremmer Elisabeth   Pötz Oliver   Joos Thomas   May Andreas   Lindemann Stephan   Gawaz Meinrad  

Basic Research in Cardiology, Vol. 104, Iss. 3, 2009-05 ,pp. : 352-357

Springer Publishing Company

Access to resources Recommend Favorite

Contemporary Trends of Optimal Evidence‐Based Medical Therapy at Discharge for Patients Surviving Acute Myocardial Infarction From the Korea Acute Myocardial Infarction Registry

By  

Clinical Cardiology, Vol. 38, Iss. 6, 2015-06 ,pp. : 350-356

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events

By Pamukcu Burak   Oflaz Huseyin   Oncul Aytac   Umman Berrin   Mercanoglu Fehmi   Ozcan Mustafa   Meric Mehmet   Nisanci Yilmaz  

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 2, 2006-10 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite

Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial

By Karjalainen Pasi  

The International Journal of Cardiovascular Imaging, Vol. 29, Iss. 8, 2013-12 ,pp. : 1693-1703

Springer Publishing Company

Access to resources Recommend Favorite